Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC
Accepted 2023-02-14 00:00:00 ET · period of report 2023-02-10 · accession 0001062993-23-003479 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-02-14 | 2023-02-13 | COLL | Kuhlmann Shirley R. | EVP, GC | S - Sale | $26.88 | -21.8K | 137.5K | -14% | -$586.3K | |
| M | 2023-02-14 | 2023-02-10 | COLL | Kuhlmann Shirley R. | EVP, GC | F - Tax | $26.75 | -24.0K | 167.1K | -13% | -$643.2K |
| M | 2023-02-14 | 2023-02-10 | COLL | Kuhlmann Shirley R. | EVP, GC | A - Grant | $0.00 | +73.9K | 157.6K | +88% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-13 | S | D | 21,811 | $26.88 | 137,502 | D | — | — | (F6) The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $26.485 to $27.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (6). |
| 2 | Common | Common Stock | 2023-02-10 | F | D | 7,755 | $26.75 | 159,313 | D | — | — | (F4) Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of performance stock units. |
| 3 | Common | Common Stock | 2023-02-10 | F | D | 16,291 | $26.75 | 167,068 | D | — | — | (F3) Shares withheld by the issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. |
| 4 | Common | Common Stock | 2023-02-10 | A | A | 25,739 | — | 183,359 | D | — | — | (F2) Effective February 10, 2023, the Compensation Committee of the Board of Directors of the issuer determined that performance-vesting criteria were met with regard to an aggregate of 25,739 performance share units granted in the issuer's three prior fiscal years. |
| 5 | Common | Common Stock | 2023-02-10 | A | A | 48,125 | $0.00 | 157,620 | D | — | — | (F1) Reflects the grant of restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. Twenty-five percent (25%) of the restricted stock units vest on February 10, 2024, and the balance of the restricted stock units vest in equal annual installments over the following three-year period, subject to the reporting person's continued service with the issuer. The restricted stock units will be settled on each applicable vesting date in shares of the issuer's common stock. |